UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Learn about wealth management strategies for families that can help secure your financial future and provide for your loved ones.
21,982 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Facing market volatility, savvy investors turn to durable brands. Here are two consumer staples stocks right now that...
Retirement changes the money math. These budgeting tips for retirees over 50 help you maximize income, cut unnecessar...
The Nasdaq has slipped into correction territory, raising questions about the next move. This guide uncovers historic...
Ready to secure your retirement with a solid plan? This 10-year roadmap shows you how to build retirement income plan...
Investors are watching a growing wave of AI IPO chatter. If OpenAI opts for a confidential filing, understanding the ...
When a beloved series delivers its most disturbing moment, fans react in many ways. This piece uses that divide to un...
Looking for value and growth in one parcel? This guide dives into the best growth etfs under $20, how to evaluate the...
An overlooked cleantech fund just delivered a powerful start to 2026, posting double-digit gains year-to-date and ecl...
Two streaming giants are pulling in opposite directions in 2026. Netflix has stumbled, while Roku gains traction. Thi...
Dreaming of a destination wedding? This budget-focused guide draws on the Venice-inspired celebrations around Giannin...
Rivian has made bold moves in a high-stakes market. With shares drifting down this year, this guide weighs the case f...